VCP and ovarian carcinoma: Previously, we reported that inhibition of growth arrest and DNA damage-inducible 34 (GADD34) by salubrinal results in synergistic cytotoxicity with VCP inhibitors, including CB-5083, in several ovarian cancer cell lines [14].